Cadre Holdings Inc (CDRE) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Cadre Holdings inc   (NYSE: CDRE)
 

Cadre Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Cadre Holdings Inc 's inventory turnover ratio sequentially decreased to 3.28 in the first quarter 2026, unsurprisingly, as the Cadre Holdings Inc markets continue to deteriorate, and CDRE's faces growing challenges to bring down its inventories. Cadre Holdings Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 111 days, from 108 days, in the Dec 31 2025 quarter.

Within Healthcare sector 115 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 833 in the fourth quarter 2025, to 995.

CDRE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cadre Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDRE Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 42.71 % 21.75 % 12.67 % 14.6 % -4.15 %
Y / Y Cost of Sales Growth 30.14 % -2.83 % 28.99 % 7.4 % -8.75 %
Inventory Turnover Ratio (TTM) 3.28 3.38 3.56 3.47 3.54
CDRE's Total Ranking # 995 # 833 # 644 # 907 # 753
Average inventory processing period 111 108 102 105 103
Seq. Inventory Growth 30.65 % -10.64 % 2.37 % 19.41 % 11.46 %
Seq. Cost of Sales Growth -1.04 % 7.87 % -3.26 % 26.03 % -26.11 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 47
Healthcare Sector # 116
Overall Market # 995

Inventory Turnover Ratio Statistics
High Average Low
3.83 3.57 3.28
(Mar 31 2022)   (Mar 31 2026)



CDRE Company Profile >> Back to CDRE Efficiency Comparisons >> Compare CDRE Inventory Turnover Ratio to its Competitors

Financial Statements
Cadre Holdings Inc 's Inventories $ 131 Millions Visit CDRE's Balance sheet
Cadre Holdings Inc 's Cost of Revenues TTM $ 372 Millions Visit CDRE's Income Statement
What are CDRE's Sales? Visit CDRE's Sales by Segment

Other Inventory Turnover Ratios
Cadre Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CDRE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CDRE's Competitors
Inventory Turnover Ratio for CDRE's Suppliers
Inventory Turnover Ratio for CDRE's Customers

You may also want to know
CDRE's Sales Growth Rates CDRE's Pe Price to earnings ratio CDRE's Receivables Turnover Ratio CDRE's Stock Quote
CDRE's Net Income Growth Rates CDRE's Ps Price to Sales ratio CDRE's Sales per Employee CDRE's Asset Turnover Ratio
CDRE's Net Margin CDRE's Pb Price to Book ratio CDRE's Financial Strength Ratios CDRE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Tarsus Pharmaceuticals Inc   7.60 $ 31.627  Millions$ 4  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions

Date modified: 2026-08-29T17:46:12+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.